Loss of function mutation for tp53 does not rescue small eye phenotype in Danio rerio
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Abstract
In Zebrafish, the chaf1b gene is in part responsible for the
development of the retina. When the chaf1b mutation, t24412, is
homozygous, cell death is promoted through a Tp53-dependent
pathway resulting in a small-eye phenotype. In our hands,
knockdown of Tp53 via morpholinos failed to rescue the smalleye phenotype found in chaf1bnt2 homozygous mutants. Because
morphants may not fully inhibit target gene function we crossed
2 fish heterozygous for nt2 (gef) and a cell-death induction
deficient allele of tp53 (zdf1) and analyzed double homozygous
mutants. Restriction fragment length polymorphism analysis was
used to verify nt2 and zdf1 alleles. We found that loss of tp53
function did not rescue the chaf1bnt2/nt2 small-eye phenotype.

Introduction
The chaf1b gene codes for a subunit of the histone loading protein
complex CAF-1 and is vital to the eye development of Zebrafish. The
good effort (gef a.k.a. nt2) allele presents as a small-eye phenotype
and results from a 3 bp deletion in intron 3 that overlaps the splice
donor site, which leads to exon 3 splicing defects and non-functional
protein (Bailey and Hyde). Chaf1b morphants phenocopy the gef
small-eye phenotype and supports the idea that loss of chaf1b function
is the cause of the gef phenotype. We tested whether addition of wildtype chaf1b mRNA could rescue gef mutant embryos. In vitro
transcribed chaf1b mRNA, subcloned from gef and wt embryos, was
injected into 1 to 2 cell embryos homozygous for gef. Mutants
injected with normal chaf1b mRNA, but not those injected with
mutant chaf1b mRNA, had bigger eyes than the mutants which did not
receive injections. Loss of chaf1b function has been hypothesized to
lead to failed histone loading on newly replicated DNA, leaving the
DNA exposed so that it becomes damaged and leads to cell arrest in
S-phase and apoptosis through a tp53-dependent pathway (Fischer et
al.). However, knock down of tp53 via morpholino injection resulted
in a failure to rescue the gef phenotype. In order to more rigorously
test this hypothesis, we tested whether a genetic loss-of-tp53-function
allele, zdf1, which fails to activate apoptosis, could rescue the gef
phenotype.

Results

The gef (nt2)mutation results in a small-eye phenotype
Figure (A). Lateral view of wt zebrafish. (B) Lateral view of gef
mutant. (C) Dorsal view of wt zebrafish. (D) Dorsal view of gef
mutant. Note the large unaffected lens protruding from the retina.

Morpholino knockdown of tp53 does
not rescue small-eye phenotype
Figure (A) Image of wt phenotype with
tp53 morpholino knockdown and
TUNEL to label cells undergoing
apoptosis. (B) gef mutant without tp53
morpholino injection and TUNEL to
label cells undergoing apoptosis. (C)
gef mutant with tp53 morpholino
injection and TUNEL to label cells
undergoing apoptosis. Note that the
dividing cells of the margin (arrows)
do not apoptose in any condition.

Injections of wild-type
chaf1b mRNA partially
rescue small-eye phenotype
(A) Right, lateral view of
wild-type embryo. Black bar
represents 100 microns.
White bar is average A-P
diameter of gef mutants (B)
Uninjected gef mutant. (C)
chaf1b exon 3 deletion
mRNA gef mutant. (D) wt
chaf1b mRNA injected gef
mutant. (E) Gel of the RNA
sequences, 2 being leftover
maternal wt RNA, 4 being
the truncated gef RNA, 1 and
3 are other RNA splice sites.
(F) size difference of
zebrafish eyes after injection
relative to wild-type.
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Loss of Tp53 function does not rescue the gef (chaf1bnt2 /nt2)
small-eye phenotype
All embryos with small eyes were analyzed at 3 dpf for tp53
zygosity using RFLP. The left panel represents embryo #3 in the
gel shown before, whereas the the right panel represents the #10
zdf1 homozygote shown in the same gel. The size of zebrafish
retina at 3 dpf is comparable to that of zebrafish which have
homozygous chaf1bnt2. Therefore, knockout via loss of function
mutation failed to rescue the small-eye phenotype.

Conclusions
Knockout of tp53 via a loss of a function mutation in
homozygous zdf1/zdf1 embryos is not sufficient to rescue gef
mutant fish (small-eye phenotype).
Rapidly dividing cells, those predicted to die by apoptosis in gef
mutants, persist longer than those which have left the cell cycle.
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Base change of defective tp53 allele, zdf1, creates a second cut site for MboII
The zdf1 allele is caused by a single T to A point mutation. This creates a second
sequence of 5’GAAGA3’ that MboII can cut the DNA at. This results in 2 bands
being present when amplicons of the zdf1 is cut by MboII into 209 bp and 127 bp
bands. The wild-type amplicon fails to cut and is seen on a gel as a 336 bp band.
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Embryo 3 (lane 5) is heterozygous.
Embryo 10 (lane 6) is homozygous mutant.
Embryos 18 and 19 (lanes 7 and 8) are homozygous wildtype embryos.
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